Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices 9343 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Generic Clearance for the Collection 

of Qualitative Feedback on Agency 

Service Delivery (OMB Control No. 

0920–1071, Exp. 2/28/2021)— 

Extension—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

CDC/NCEZID is seeking a three-year 

extension of OMB control No. 0920– 

1071 to continue collecting routine 

customer feedback on agency service 

delivery. Executive Order 12862 directs 

Federal agencies to provide service to 

the public that matches or exceeds the 

best service available in the private 

sector. In order to work continuously to 

ensure that our programs are effective 

and meet our customers’ needs, the 

National Center for Emerging and 

Zoonotic Infectious Diseases, Centers for 

Disease Control and Prevention (CDC) 

(hereafter the ‘‘Agency’’) seeks to obtain 

OMB approval of a generic clearance to 

collect qualitative feedback on our 

service delivery. By qualitative feedback 

we mean information that provides 

useful insights on perceptions and 

opinions, but are not statistical surveys 

that yield quantitative results that can 

be generalized to the population of 

study. 

This collection of information is 

necessary to enable the Agency to garner 

customer and stakeholder feedback in 

an efficient, timely manner, in 

accordance with our commitment to 

improving service delivery. The 

information collected from our 

customers and stakeholders will help 

ensure that users have an effective, 

efficient, and satisfying experience with 

the Agency’s programs. This feedback 

will provide insights into customer or 

stakeholder perceptions, experiences 

and expectations, provide an early 

warning of issues with service, or focus 

attention on areas where 

communication, training or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between the 

Agency and its customers and 

stakeholders. It will also allow feedback 

to contribute directly to the 

improvement of program management. 

Since getting approval in February 

2018, NCEZID has utilized 0920–1071 

ten separate times. The total number of 

responses was 15,585. The total number 

of burden hours was 2,525. Authorizing 

legislation for this collection comes 

from Section 301 of the Public Health 

Service Act (42 U.S.C. 241). The 

estimated annual burden hours 

requested for this Extension are 3,850. 

There is no cost to respondents other 

than the time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

General public ................................................. Online surveys ............................................... 1500 1 30/60 

Focus groups ................................................. 800 1 2 

In-person surveys ........................................... 1000 1 30/60 

Usability testing .............................................. 1500 1 30/60 

Customer comment cards .............................. 1000 1 15/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–02948 Filed 2–11–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21CT; Docket No. CDC–2021– 

0006] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

request for emergency clearance of the 

information collection titled 

Requirement for Negative Pre-Departure 

Covid–19 Test Result or Documentation 

of Recovery from Covid–19 for all 

Airline or other Aircraft Passengers 

arriving into the United States from any 

foreign country. This collection 

accompanies a CDC Order of the same 

name and is designed to prohibit the 

introduction into the United States of 

any airline passenger departing from the 

any foreign country unless the 

passenger: 

(1) Has a negative pre-departure test 

result for COVID–19 (Qualifying Test), 

or (2) has written or electronic 

documentation of recovery from 

COVID–19 in the form of a positive viral 

test result and a letter from a licensed 

health care provider or public health 

official stating that the passenger has 

been cleared for travel. 

DATES: CDC must receive written 

comments on or before April 13, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0006 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

9344 Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices 

instruments, contact Jeffrey M. Zirger, of 

the Information Collection Review 

Office, Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Requirement for Negative PreDeparture Covid–19 Test Result or 

Documentation of Recovery From 

Covid–19 for all Airline or other Aircraft 

Passengers Arriving into the United 

States from any Foreign Country— 

New—National Center for Emerging 

Zoonotic and Infectious Diseases 

(NCEZID), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

This information collection 

accompanies the Notice and Order 

named above. Pursuant to 42 CFR 71.20 

and as set forth in greater detail below, 

this Notice and Order prohibit the 

introduction into the United States of 

any airline passenger departing from the 

any foreign country unless the 

passenger: 

(1) Has a negative pre-departure test 

result for COVID–19 (Qualifying Test), 

or (2) has written or electronic 

documentation of recovery from 

COVID–19 in the form of a positive viral 

test result and a letter from a licensed 

health care provider or public health 

official stating that the passenger has 

been cleared for travel (Documentation 

of Recovery). 

The negative test must be a viral test 

that was conducted on a specimen 

collected during the three days 

preceding the flight’s departure from a 

foreign country. Passengers must retain 

written or electronic documentation 

reflecting the Qualifying Test, or 

Documentation of Recovery, presented 

to the airline and produce such 

documentation upon request to any U.S. 

government official or a cooperating 

state or local public health authority. 

Pursuant to 42 CFR 71.31(b), the 

Order constitutes a controlled free 

pratique to any airline with an aircraft 

arriving into the United States from any 

foreign country. Pursuant to the 

controlled free pratique, the airline must 

comply with the following conditions in 

order to receive permission for the 

aircraft to enter and disembark 

passengers in the United States: 

• Airline or other aircraft operator 

must verify that every passenger—two 

years of age or older—onboard the 

aircraft has attested to receiving a 

negative Qualifying Test result or to 

having recovered from COVID–19 after 

previous SARS–CoV–2 infection and 

being cleared to travel by a licensed 

health care provider or public health 

official. 

• Airline or other aircraft operator 

must confirm that every passenger 

onboard the aircraft has documentation 

of a negative Qualifying Test result or 

Documentation of Recovery from 

COVID–19. 

Certain exemptions and waivers do 

apply, and are as follows: 

• Crew members of airlines or other 

aircraft operators provided that they 

follow industry standard protocols for 

the prevention of COVID–19 as set forth 

in relevant Safety Alerts for Operators 

(SAFOs) issued by the Federal Aviation 

Administration (FAA). 

• Airlines or other aircraft operators 

transporting passengers with COVID–19 

pursuant to CDC authorization and in 

accordance with CDC guidance. 

• Federal law enforcement personnel 

on official orders who are traveling for 

the purpose of carrying out a law 

enforcement function, provided they are 

covered under an occupational health 

and safety program in accordance with 

CDC guidance. Those traveling for 

training or other business purposes 

remain subject to the requirements of 

this Order. 

• U.S. Department of Defense (DOD) 

personnel, including military personnel 

and civilian employees, dependents, 

contractors (including whole aircraft 

charter operators), and other U.S. 

government employees when traveling 

on DOD assets, provided that such 

individuals are under competent 

military or U.S government travel orders 

and observing DOD precautions to 

prevent the transmission of COVID–19 

as set forth in Force Protection 

Guidance Supplement 14—Department 

of Defense Guidance for Personnel 

Traveling During the Coronavirus 

Disease 2019 Pandemic (December 29, 

2020) including its testing guidance. 

• Individuals and organizations for 

which the issuance of a humanitarian 

exemption is necessary based on both 

(1) exigent circumstances where 

emergency travel is required to preserve 

health and safety (e.g., emergency 

medical evacuations) and (2) where predeparture testing cannot be accessed or 

completed before travel. Additional 

conditions may be placed on those 

granted such exemptions, including but 

not limited to, observing precautions 

during travel, providing consent to postarrival testing, and/or self-quarantine 

after arrival in the United States, as may 

be directed by federal, state, territorial, 

tribal or local public health authorities 

to reduce the risk of transmission or 

spread. 

CDC anticipates certain additional 

cost burdens to respondents and record 

keepers due to the requirements. These 

costs fall into the following categories: 

• Traveler testing and ancillary costs: 

$9,136,480,000. 

• Traveler deferred travel costs: 

$44,370,000. 

• Airline staff costs for digitizing 

attestations: $12,257,000. 

• Airline costs to store attestations: 

$1,200–$1,050,000 a year depending on 

size of airline and number of travelers. 

Estimated burden hours associated 

with this collection are 70,843,733. 

Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices 9345 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Traveler (3rd Party Disclosure) ......... Attestation of a negative COVID–19 

test/Documentation indicating 

clearance for travel by a licensed 

healthcare provider or public 

health official.

34,000,000 1 2 68,000,000 

Airline Desk Agent ............................ Attestation of a negative COVID–19 

test/Documentation indicating 

clearance for travel by a licensed 

healthcare provider or public 

health official.

34,000,000 1 5/60 2,833,333 

Traveler ............................................. Request Exemption on Urgent Humanitarian Basis.5,200 1 2 10,400 

Total ........................................... ........................................................... ........................ ........................ ........................ 70,843,733 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–02951 Filed 2–11–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21CM; Docket No. CDC–2021– 

0009] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed and/or 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National Center 

for Health Statistics’ Research and 

Development Survey (RANDS) during 

COVID–19—Round 3. The Research and 

Development Survey (RANDS) is 

designed to quickly obtain and 

disseminate information about selected 

population health characteristics during 

the ongoing coronavirus pandemic, and 

to provide documentation supporting 

the validity of pandemic-related survey 

questions, including questions, such as 

those on telehealth access and use, that 

will continue to be important for public 

health after the pandemic. 

DATES: Written comments must be 

received on or before April 13, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0009 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to Regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

Regulations.gov. 

Please note: All public comment 

should be submitted through the 

Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

National Center for Health Statistics 

Research and Development Survey 

(RANDS) during COVID–19 (Round 3)— 

New—National Center for Health 

Statistics (NCHS), Centers for Disease 

Control and Prevention (CDC).